Author Gross, Oliver

1 to 20 of 56 Items
  • 2024 | Journal Article
    ​ ​SGLT2 inhibitors: approved for adults and cats but not for children with CKD​
    Gross, O.; Haffner, D.; Schaefer, F. & Weber, L. T​ (2024) 
    Nephrology Dialysis Transplantation, art. gfae029​.​ DOI: https://doi.org/10.1093/ndt/gfae029 
    ​Details  DOI 
  • 2023 | Journal Article | 
    ​ ​Ratio of Urinary Proteins to Albumin Excretion Shifts Substantially during Progression of the Podocytopathy Alport Syndrome, and Spot Urine Is a Reliable Method to Detect These Pathologic Changes​
    Boeckhaus, J.; Mohr, L.; Tönshoff, B.; Weber, L. T.; Pape, L.; Latta, K. & Fehrenbach, H. et al.​ (2023) 
    Cells, 12(9) pp. 1333​.​ DOI: https://doi.org/10.3390/cells12091333 
    ​Details  DOI 
  • 2023 | Journal Article
    ​ ​Okuläre Veränderungen bei Patienten mit Alport-Syndrom – ein Update​
    Pfau, K.; Gross, O.; Bemme, S.; Meyer, P.; Take, P.; Boeckhaus, J. & Holz, F. G. et al.​ (2023) 
    Die Ophthalmologie,.​ DOI: https://doi.org/10.1007/s00347-022-01805-1 
    ​Details  DOI 
  • 2023 | Journal Article
    ​ ​Finerenone Added to RAS/SGLT2 Blockade for CKD in Alport Syndrome. Results of a Randomized Controlled Trial with Col4a3 −/− Mice​
    Zhu, Z.; Rosenkranz, K. A.; Kusunoki, Y.; Li, C.; Klaus, M.; Gross, O. & Angelotti, M.-L. et al.​ (2023) 
    Journal of the American Society of Nephrology, 34(9) pp. 1513​-1520​.​ DOI: https://doi.org/10.1681/ASN.0000000000000186 
    ​Details  DOI 
  • 2023 | Journal Article
    ​ ​Genetic Modifiers of Mendelian Monogenic Collagen IV Nephropathies in Humans and Mice​
    Deltas, C.; Papagregoriou, G.; Louka, S. F.; Malatras, A.; Flinter, F.; Gale, D. P. & Gear, S. et al.​ (2023) 
    Genes, 14(9) pp. 1686​.​ DOI: https://doi.org/10.3390/genes14091686 
    ​Details  DOI 
  • 2023 | Journal Article
    ​ ​Urinary Protein-Biomarkers Reliably Indicate Very Early Kidney Damage in Children With Alport Syndrome Independently of Albuminuria and Inflammation​
    Rhode, H.; Lüse, A.; Tautkus, B.; Nabity, M.; John-Kroegel, U.; Weigel, F. & Dost, A. et al.​ (2023) 
    Kidney International Reports, 8(12) pp. 2778​-2793​.​ DOI: https://doi.org/10.1016/j.ekir.2023.09.028 
    ​Details  DOI 
  • 2022 | Journal Article | Research Paper | 
    ​ ​Anti-microRNA-21 Therapy on Top of ACE Inhibition Delays Renal Failure in Alport Syndrome Mouse Models​
    Rubel, D.; Boulanger, J.; Craciun, F.; Xu, E. Y.; Zhang, Y.; Phillips, L. & Callahan, M. et al.​ (2022) 
    Cells, 11(4).​ DOI: https://doi.org/10.3390/cells11040594 
    ​Details  DOI 
  • 2022 | Journal Article
    ​ ​Lifelong effect of therapy in young patients with the COL4A5 Alport missense variant p.(Gly624Asp): a prospective cohort study​
    Boeckhaus, J.; Hoefele, J.; Riedhammer, K. M; Nagel, M.; Beck, B. B; Choi, M. & Gollasch, M. et al.​ (2022) 
    Nephrology Dialysis Transplantation, art. gfac006​.​ DOI: https://doi.org/10.1093/ndt/gfac006 
    ​Details  DOI 
  • 2021 | Journal Article | Overview | 
    ​ ​Addressing the ‘hypoxia paradox’ in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues​
    Begemann, M.; Gross, O.; Wincewicz, D.; Hardeland, R.; Daguano Gastaldi, V.; Vieta, E. & Weissenborn, K. et al.​ (2021) 
    Molecular Medicine, 27(1) art. 120​.​ DOI: https://doi.org/10.1186/s10020-021-00381-5 
    ​Details  DOI  PMID  PMC 
  • 2021 | Journal Article | 
    ​ ​Case Report: Eculizumab and ECMO Rescue Therapy of Severe ARDS in Goodpasture Syndrome​
    Sobotta, M.; Moerer, O. & Gross, O.​ (2021) 
    Frontiers in Medicine, 8.​ DOI: https://doi.org/10.3389/fmed.2021.720949 
    ​Details  DOI 
  • 2021 | Journal Article
    ​ ​Update zu: COVID-19 und die Niere – Klinik​
    Böckhaus, J.; Plüß, M.; Tampe, B. & Gross, O.​ (2021) 
    Der Nephrologe, 16(5) pp. 314​-318​.​ DOI: https://doi.org/10.1007/s11560-021-00530-1 
    ​Details  DOI 
  • 2021 | Journal Article
    ​ ​Potenzieller Podozytenschaden durch Bardoxolone in klinischen Studien​
    Gross, O.​ (2021) 
    Der Nephrologe, 17(1) pp. 57​-58​.​ DOI: https://doi.org/10.1007/s11560-021-00548-5 
    ​Details  DOI 
  • 2021 | Journal Article
    ​ ​Neuer Therapieansatz für Podozytopathien​
    Gross, O.​ (2021) 
    Die Nephrologie, 17(4) pp. 259​-260​.​ DOI: https://doi.org/10.1007/s11560-021-00549-4 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndrome​
    Gross, O.; Tönshoff, B.; Weber, L. T.; Pape, L.; Latta, K.; Fehrenbach, H. & Lange-Sperandio, B. et al.​ (2020) 
    Kidney International, 97(6) pp. 1275​-1286​.​ DOI: https://doi.org/10.1016/j.kint.2019.12.015 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​COVID-19 und die Niere – Klinik​
    Gross, O.​ (2020) 
    Der Nephrologe, 16(1) pp. 26​-32​.​ DOI: https://doi.org/10.1007/s11560-020-00470-2 
    ​Details  DOI 
  • 2019 | Journal Article | 
    ​ ​Genetische Ursachen und Therapie beim Alport-Syndrom​
    Gross, O. & Hoefele, J.​ (2019) 
    Medizinische Genetik,(4) pp. 429​-437​.​ DOI: https://doi.org/10.1007/s11825-018-0214-2 
    ​Details  DOI 
  • 2019 | Journal Article | Research Paper | 
    ​ ​Kidney Injury by Variants in the COL4A5 Gene Aggravated by Polymorphisms in Slit Diaphragm Genes Causes Focal Segmental Glomerulosclerosis.​
    Frese, J.; Kettwig, M.; Zappel, H.; Hofer, J.; Gröne, H.-J.; Nagel, M. & Sunder-Plassmann, G. et al.​ (2019) 
    International Journal of Molecular Sciences, 20(3) art. 519​.​ DOI: https://doi.org/10.3390/ijms20030519 
    ​Details  DOI  PMID  PMC 
  • 2019 | Journal Article | 
    ​ ​The importance of clinician, patient and researcher collaborations in Alport syndrome​
    Rheault, M. N.; Savige, J.; Randles, M. J.; Weinstock, A.; Stepney, M.; Turner, A N. & Parziale, G. et al.​ (2019) 
    Pediatric Nephrology, pp. 1​-10​.​ DOI: https://doi.org/10.1007/s00467-019-04241-7 
    ​Details  DOI  PMID  PMC 
  • 2017 | Review
    ​ ​Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport Syndrome​
    Gross, O.; Kashtan, C. E.; Rheault, M. N.; Flinter, F.; Savige, J.; Miner, J. H.& Torra, R. et al.​ (2017)
    Nephrology Dialysis Transplantation, 32​(6) pp. 916​-924​.​
    Oxford Univ Press. DOI: https://doi.org/10.1093/ndt/gfw095 
    ​Details  DOI  PMID  PMC  WoS 
  • 2017 | Journal Article
    ​ ​Prospective study on the potential of RAAS blockade to halt renal disease in Alport syndrome patients with heterozygous mutations​
    Stock, J.; Kuenanz, J.; Glonke, N.; Sonntag, J.; Frese, J.; Toenshoff, B. & Hoecker, B. et al.​ (2017) 
    Pediatric Nephrology, 32(1) pp. 131​-137​.​ DOI: https://doi.org/10.1007/s00467-016-3452-z 
    ​Details  DOI  PMID  PMC  WoS 

Researcher

Göttingen All

Sort

issue date

ASC DESC

Items per Page

10 20 50 100